Effect of curcumin on the intensity of dysmenorrhea pain

Investigating the effect of curcumin on the intensity of dysmenorrhea pain in endometriosis patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20201121049457N1

Enrollment

Registered

2021-09-14

Start date

2021-09-11

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis. Endometriosis

Interventions

Intervention 1: Intervention group: daily administration of two 40 mg curcumin capsules in the intervention group for three months. Intervention 2: Control group: two placebo capsules in the control g

Eligibility

Sex/Gender

Female

Age

15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Diagnosis of endometriosis based on ultrasound, MRI or surgery (based on persistent cysts or typical endometriosis profile) Complaints of dysmenorrhea Age 15-45 years old Informed written consent to participate in the study

Exclusion criteria

Exclusion criteria: Treatment with GnRH agonist drugs Intention to get pregnant

Design outcomes

Primary

Measure	Time frame
Severe dysmenorrhea pain. Timepoint: Once every seven days. Method of measurement: By 10-point visual analogue scale (VAS).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Hatami

Mashhad University of Medical Sciences

shima.hatami69@gmail.com+98 51 3802 2608

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026